These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Doppler ultrasound measurement of cardiac output in patients with physiologic pacemakers. Effects of left ventricular function and retrograde ventriculoatrial conduction. Author: Stewart WJ, Dicola VC, Harthorne JW, Gillam LD, Weyman AE. Journal: Am J Cardiol; 1984 Aug 01; 54(3):308-12. PubMed ID: 6465010. Abstract: Dual-chamber cardiac pacing (DDD) offers obvious theoretical advantages over traditional ventricular demand (VVI) pacing. Nevertheless, no widely agreed upon criteria exist for the selection of patients for physiologic DDD pacemakers compared with the simpler VVI systems. Accordingly, a non-invasive method for measuring cardiac output (Doppler ultrasound) was used to identify candidates for pacing who would derive the greatest hemodynamic benefit from DDD vs VVI pacing. Among 29 patients studied at rest during VVI-mode pacing, the average cardiac output by Doppler ultrasound was 4.3 +/- 0.3 liters/min (mean +/- standard error of the mean). In the DDD mode, the average cardiac output was 5.0 +/- 0.3 liters/min (p less than 0.001). Baseline left ventricular ejection fraction did not identify a group that improved more with DDD pacing. Patients who showed either retrograde ventriculoatrial conduction or described symptoms consistent with the "pacemaker syndrome" during VVI pacing, however, showed greater increases in cardiac output during DDD pacing. In these patients, the mean improvement in cardiac output was 30.4 +/- 8.6% with DDD vs VVI pacing, as opposed to an average increase of only 14.4 +/- 3.4% in the remaining 20 patients (p = 0.02). Thus, Doppler ultrasound can be used to quantitate the change in cardiac output at rest that occurs with DDD vs VVI pacing. The change is independent of the level of left ventricular function but is substantially higher when there is evidence of ventriculoatrial conduction or the pacemaker syndrome.[Abstract] [Full Text] [Related] [New Search]